Profile data is unavailable for this security.
About the company
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
- Revenue in USD (TTM)17.86m
- Net income in USD-3.67m
- Incorporated2019
- Employees216.00
- LocationUniverse Pharmaceuticals Inc265 Jingjiu AvenueJinggangshan Econ. And Tech. Dev. ZoneJI'AN 343100ChinaCHN
- Phone+86 7 968403309
- Websitehttp://www.universe-pharmacy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| American Green Inc | -100.00bn | -100.00bn | 868.45k | 6.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Pure Harvest Corporate Group Inc | 2.48m | -6.67m | 879.61k | 25.00 | -- | 0.3903 | -- | 0.3552 | -0.0901 | -0.0901 | 0.0383 | 0.0201 | 0.2644 | 1.46 | 40.64 | 99,070.40 | -70.96 | -- | -136.76 | -- | 33.83 | -- | -268.37 | -- | 0.5886 | -0.866 | 0.7639 | -- | 1,808.41 | -- | -459.26 | -- | -- | -- |
| ITonis Inc | 0.00 | -1.17m | 914.05k | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -187.63 | -- | -1,169.36 | -- | -- | -- | -- | -- | -- | -0.8999 | -- | -- | -- | -- | -506.86 | -- | -- | -- |
| Vitalibis Inc | 243.57k | -3.96m | 986.42k | 0.00 | -- | -- | -- | 4.05 | -0.1103 | -0.1103 | 0.0034 | -0.0069 | 0.5201 | 0.352 | -- | -- | -844.71 | -1,100.84 | -- | -- | 51.56 | -- | -1,624.14 | -2,623.60 | 0.5512 | -2.33 | -- | -- | 490.69 | -- | -207.18 | -- | -- | -- |
| Evofem Biosciences Inc | 17.73m | -5.56m | 1.10m | 32.00 | -- | -- | -- | 0.0622 | -0.058 | -0.058 | 0.0111 | -0.5661 | 0.9392 | 2.25 | 3.61 | 553,937.50 | -28.79 | -177.41 | -- | -- | 80.05 | 69.60 | -30.66 | -602.27 | 0.0797 | -0.2439 | -- | -- | 6.28 | -- | -117.93 | -- | -38.87 | -- |
| Onconetix Inc | 1.22m | -50.85m | 1.20m | 5.00 | -- | 0.3581 | -- | 0.9839 | -350.74 | -350.74 | 2.14 | 2.16 | 0.03 | 1.31 | 24.33 | 244,750.00 | -120.44 | -82.49 | -240.72 | -114.71 | 85.41 | -- | -4,015.56 | -4,434.98 | 0.0706 | -17.94 | 0.0453 | -- | 4,216.95 | -- | -57.44 | -- | 44.62 | -- |
| Procyon Corp | 4.98m | -312.97k | 1.53m | 19.00 | -- | 0.7027 | -- | 0.307 | -0.0387 | -0.0387 | 0.6138 | 0.2817 | 1.47 | 2.32 | 9.90 | 262,338.40 | -10.08 | 1.19 | -12.70 | 1.44 | 78.07 | 74.40 | -6.84 | 0.8691 | 2.41 | -- | 0.00 | -- | 6.35 | 3.53 | -367.38 | -- | 17.32 | -- |
| Universe Pharmaceuticals Inc | 17.86m | -3.67m | 1.61m | 216.00 | -- | 0.0287 | -- | 0.0902 | -10.13 | -10.13 | 39.18 | 99.64 | 0.2602 | 5.88 | 1.38 | 82,679.35 | -5.35 | -5.40 | -7.08 | -7.09 | 35.28 | 43.33 | -20.56 | -9.65 | 3.90 | -17.46 | 0.1416 | -- | -22.44 | -10.27 | 57.92 | -- | 46.30 | -- |
| Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 1.90m | 40.00 | -- | -- | -- | 0.6858 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 2.58 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Bio Essence Corp | 565.67k | -160.45k | 2.08m | 2.00 | -- | -- | -- | 3.67 | -0.0042 | -0.0042 | 0.0149 | -0.0816 | 1.26 | -- | 16.06 | 282,835.00 | -35.64 | -40.94 | -- | -- | 69.28 | 38.36 | -28.36 | -134.00 | -- | -57.42 | -- | -- | -- | -17.08 | -286.98 | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 2.21m | 16.00 | 284.00 | 3.09 | -- | 3.09 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PRF Technologies Ltd | 0.00 | -4.09m | 2.32m | 2.00 | 0.0098 | 0.1412 | -- | -- | 301.27 | 301.27 | 0.00 | 20.97 | 0.00 | -- | -- | 0.00 | -57.27 | -71.03 | -118.06 | -84.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.12 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Universe Pharmaceuticals Inc's reporting currency: US Dollar USD
19.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sabby Management LLCas of 31 Dec 2025 | 28.11k | 15.45% |
| Gesalcal� SA SGIICas of 31 Dec 2025 | 4.95k | 2.72% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Sep 2025 | 2.00k | 1.10% |
| UBS Securities LLCas of 31 Dec 2025 | 946.00 | 0.52% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
